Journal profile · Medicine, Research & Experimental
European journal of medical research
ISSN 0949-2321 · eISSN 2047-783X · BioMed Central · GERMANY · Monthly · Founded 2009
European journal of medical research: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.77; fully open access; APC about USD 3,190; median 153 days to acceptance (97 articles, last 24 months); community-reported acceptance: easy; 1,468 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
European journal of medical research is published by BioMed Central and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Ferroptosis and cancer prognosis, Sepsis Diagnosis and Treatment and Inflammatory Biomarkers in Disease Prognosis, together about 26.4% of its articles. Its main subfields are Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
European Journal of Medical Research aims to support and publish research into the causes, characteristics, diagnosis and treatment of human disorders and disease. We will consider translational, preclinical and clinical research across all medical disciplines, enabling clinicians and other researchers to learn about developments and innovations within and across the boundaries between these disciplines. European Journal of Medical Research publishes high quality ethically-conducted research and reviews and aims to ensure that the results of all well-conducted research are published, regardless of their outcome. Section Topics covered Circulation Cardiology, Hypertension, Peripheral vascular disease, cerebrovascular disease and their related epidemiology, pathology, genetics, diagnostics and imaging, prevention and treatments. Infection, Inflammation and Immunity Infection, sepsis, vaccination, immunodeficiency, autoimmune disease and their related epidemiology, pathology, genetics, diagnostics and imaging, prevention and treatments. Oncology Benign and malignant neoplastic disease and their related epidemiology, pathology, genetics, diagnostics and imaging, prevention and treatments including palliative care. Surgery and Therapeutic Innovation All surgery including neurosurgery, thoracic surgery, ENT, opthalmic, urology, transplantation and orthopaedic surgery. Novel therapeutics and devices. Neuroscience Neurology, dementia and cognitive decline, mental health and neurorehabilitation and their related epidemiology, pathology, genetics, diagnostics and imaging, prevention and treatments. Metabolism and Reproductive Medicine Diabetes, obesity, metabolic disease, endocrinology, male and female infertility, menopause and related gynaecological and obstetric disorders and their related epidemiology, pathology, genetics, diagnostics and imaging, prevention and treatments. Detailed criteria are listed in the Submission Guidelines for Research articles and Reviews. Please review them before submitting your manuscript.
From the journal's Aims & Scope
Research area (LetPub): Medicine, Research & Experimental
Editor-in-chief Adrian J.L.Publisher website
Editorial board by country: 65 in mainland China (about 24%); most named Mainland China 65, United States 36, Italy 36, India 21, Germany 15 (272 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Ferroptosis and cancer prognosisMedicine9.9%
- Sepsis Diagnosis and TreatmentMedicine9.4%
- Inflammatory Biomarkers in Disease PrognosisMedicine7%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine4.1%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine4%
- Respiratory Support and MechanismsMedicine3.8%
- Liver Disease Diagnosis and TreatmentMedicine3.8%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.77LetPub ·
- CiteScore 2026-06
- 3.2LetPub ·
- SJR 2026-06
- 0.74LetPub ·
- SNIP 2026-06
- 0.82LetPub ·
- h-index
- 51LetPub ·
- h-index
- 80OpenAlex ·
- i10-index
- 1,464OpenAlex ·
- 2-year mean citedness
- 3.53OpenAlex ·
- Self-citation rate
- 2.1%LetPub ·
- Share of gold OA articles
- 99.96%LetPub ·
Volume
- Articles per year
- 1,452LetPub ·
Articles by year OpenAlex count · 5,611 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,456 | 1,456 | 369 |
| 2025 | 1,468 | 1,468 | 5,526 |
| 2024 | 643 | 643 | 6,696 |
| 2023 | 616 | 616 | 9,004 |
| 2022 | 318 | 318 | 4,971 |
| 2021 | 152 | 152 | 3,266 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
153 daysMedian, submission to acceptance · P25–P75 95 days – 189 days
- Acceptance to online
- median 14 days (97 articles)
- Submission to online
- median 170 days
- Sample
- 97 articles with submission and acceptance dates (2,035 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Peer review
- Anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,190 / EUR 2,690 / GBP 2,290 | — | — | |
| LetPub | GBP 2,190 / USD 3,090 / EUR 2,590 | Yes | — | |
| Publisher website | GBP 2,490 / USD 3,390 / EUR 2,890 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. European Journal of Medical Research articles are published open access under a CC BY-NC-ND (Creative Common…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- GERMANY
- Language
- English
- Frequency
- Monthly
- Founded
- 2009
- ISSN
- 0949-2321
- Electronic ISSN
- 2047-783X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about European journal of medical research
What CAS zone is European journal of medical research in?
In the 2025 upgraded edition of the CAS Journal Ranking, European journal of medical research is in Zone 3 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European journal of medical research?
The latest impact factor listed by LetPub is 4.77; CiteScore 3.2, h-index 80.
How long does peer review take at European journal of medical research?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 153 days (interquartile range 95–189 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of European journal of medical research based?
Of the 272 board members whose country the journal's board page names, 65 (about 24%) are in mainland China; the countries named most often are Mainland China (65), United States (36) and Italy (36). Counted from the institutions listed on the board page; for reference only.
Which databases index European journal of medical research?
According to LetPub and DOAJ records, European journal of medical research is indexed in SCIE, Scopus and DOAJ.
Is European journal of medical research open access, and what is the APC?
European journal of medical research is a fully open-access journal. APC about USD 3,190.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .